The association between somatic JAK2 mutation and myeloproliferative neoplasms (MPNs) is now well established. However, because JAK2 mutations are associated with heterogeneous clinical phenotypes and often occur as secondary genetic events, some aspects of JAK2 mutation biology remain to be understood. We recently described a germline JAK2V617I mutation in a family with hereditary thrombocytosis and herein characterize the hematopoietic and signaling impact of JAK2V617I. Through targeted seq...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record